1. Food and Drug Administration: Assay Development and Validation for Immunogenicity Testing of Therapeutic Protein Products (Guidance for Industry Draft FDA,2016
2. Guideline on Immunogenicity Assessment of Therapeutic Proteins,2017
3. Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose;Chung;N Engl J Med,2008
4. Pure red-cell aplasia and anti-erythropoietin antibodies in patients treated with recombinant erythropoietin;Casadevall;N Engl J Med,2002
5. Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights;Macdougall;Kidney Int,2012